Rest Of Europe Blood Culture Tests Market (2026-2031)
The Rest Of Europe Blood Culture Tests Market was valued at $399.1 Million in 2026 and projected to reach to $615.1 Million by 2031, representing a compound annual growth rate of 9.0%. Rest Of Europe's blood culture tests market demonstrates exceptional growth potential, driven by enhanced healthcare infrastructure investments and increasing clinical demand for accurate sepsis diagnostics.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Blood Culture Tests Market Trends and Insights
- This 9.0% compound annual growth rate significantly outpaces the global average, reflecting strong regional demand for diagnostic solutions and improved healthcare infrastructure across Rest Of Europe.
- The market growth in Rest Of Europe is driven by increasing prevalence of bloodstream infections, rising adoption of automated culture systems, and enhanced laboratory capabilities throughout the region. Rest Of Europe's blood culture testing sector benefits from aging populations and heightened awareness of sepsis management protocols.
- Between 2026 and 2031, Rest Of Europe is expected to see accelerated investment in microbiology laboratories and point-of-care testing technologies.
- The region's regulatory environment and reimbursement policies continue to support market expansion, positioning Rest Of Europe as a key growth market within the broader European blood culture tests landscape..
Key Market Statistics
- CAGR (2026-2031) 9.0% CAGR
- Market Size, 2026 ~USD 399.1 Million
- Forecast, 2031 ~USD 615.1 Million
- Country Rest Of Europe
Rest Of Europe Blood Culture Tests Market Overview
Strong Regional Growth Trajectory :
Rest Of Europe's blood culture tests market is expanding at 9.0% CAGR, significantly outpacing the global average of 6.1%, demonstrating robust regional demand and market maturity.
Substantial Market Valuation :
The market is valued at USD 399.1 million in 2026 and is projected to reach USD 615.1 million by 2031, representing a growth of USD 216 million over the five-year forecast period.
Healthcare Infrastructure Investment :
Improved healthcare infrastructure and diagnostic capabilities across Rest Of Europe are driving adoption of advanced blood culture testing solutions in clinical laboratories and hospitals.
Diagnostic Solution Demand :
Rising prevalence of bloodstream infections and sepsis cases across Rest Of European countries is fueling demand for rapid and accurate blood culture diagnostic tests.
Rest Of Europe Blood Culture Tests Market Dynamics
- The region's 9.0% CAGR reflects strong adoption of advanced diagnostic technologies and improved laboratory capabilities across multiple countries. The forecast period through 2031 indicates sustained expansion as healthcare providers prioritize rapid pathogen identification and antimicrobial stewardship programs.
- Growing awareness of bloodstream infection management and regulatory support for diagnostic innovation will continue to propel market growth, positioning Rest Of Europe as a high-growth region within the global blood culture testing landscape..
Market Ecosystem
BLOOD CULTURE TESTS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides BD BACTEC automated blood culture systems and culture media/bottles for detecting bacterial and fungal bloodstream infections across hospital and clinical microbiology laboratories | Enables continuous automated monitoring | Supports earlier detection of microbial growth | Improves laboratory workflow efficiency | Supports pathogen identification and subsequent AST workflows |
 |
Provides BACT/ALERT blood culture systems and culture bottles for automated detection of bloodstream infections, complemented by microbial identification and antimicrobial susceptibility testing solutions | Enables automated detection of bloodstream pathogens | Supports integrated microbiology workflows | Facilitates faster organism identification and susceptibility testing | Supports antimicrobial stewardship |
 |
Provides Oxoid blood culture and microbiology solutions, including culture media and related products used for cultivation, isolation, and subsequent characterization of microorganisms associated with bloodstream infections | Supports recovery and isolation of bloodstream pathogens | Provides broad microbiology workflow support | Enables downstream microbial identification and susceptibility testing | Supports routine clinical laboratory testing |
 |
Provides molecular diagnostic solutions through Luminex technology, including multiplex assays that can support rapid identification of pathogens and resistance markers associated with bloodstream infections, including testing from positive blood cultures where applicable | Accelerates pathogen identification | Enables multiplex detection of clinically relevant targets | Supports earlier treatment optimization | Complements conventional culture-based workflows |
 |
Through Beckman Coulter Diagnostics, provides microbiology solutions supporting microbial identification and antimicrobial susceptibility testing, complementing blood culture workflows after microbial growth is detected | Supports identification of bloodstream isolates | Enables antimicrobial susceptibility assessment | Improves laboratory workflow efficiency | Supports targeted antimicrobial treatment decisions |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Key Takeaways
- Rest Of Europe's blood culture tests market will grow from USD 399.1M (2026) to USD 615.1M (2031) at a 9.0% CAGR.
- Rest Of Europe's growth rate exceeds the global CAGR of 6.1%, indicating accelerating regional demand and market maturation.
- Aging demographics and sepsis awareness initiatives are primary growth catalysts driving expansion across Rest Of Europe.
- Rest Of Europe represents a high-priority market for diagnostic manufacturers seeking European market penetration beyond Western Europe.
Blood Culture Tests Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | REFERENCE LABORATORIES (End User) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 6.1% from 2026 to 2031 |
| Largest Segment | BACTEREMIA (Application) |
| Market Size Base Year (Billions) | ~USD 6.65 (2026) |
| Revenue Forecast (Billions) | ~USD 8.94 (2031) |
| Segments Covered | Offering, Type, Method, Technology, Application, End User |
Rest Of Europe Blood Culture Tests Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Consumables
- Instruments
- Software & Services
By Type
- Aerobic Blood Culture Media
- Anaerobic Blood Culture Media
- Assay Kits & Reagents
- Automated Blood Culture Systems
- Blood Culture Accessories
- Blood Culture Media
- Colony Counters
- Fungi/Yeast Blood Culture Media
- Gram Stainers
- Incubators
- Microarrays
- Microscopes
- Mycobacterial Blood Culture Media
- Other Supporting Equipment
- Pcr
- Pediatric Aerobic Blood Culture Media
- Pna-Fish
- Supporting Laboratory Equipment
By Method
- Automated Blood Cultures
- Conventional/Manual Blood Cultures
By Technology
- Culture-Based Technologies
- Molecular Technologies
- Other Technologies
By Application
- Bacteremia
- Fungemia
- Mycobacterial Detection
By End User
- Academic & Research Laboratories
- Hospital Laboratories
- Other End Users
- Reference Laboratories
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies need Rest Of Europe-specific market data to develop regional product strategies, identify growth opportunities, and allocate R&D resources for the high-growth diagnostic market.
- Healthcare System Administrators : Hospital networks and laboratory directors require market insights to benchmark procurement strategies, evaluate supplier options, and optimize blood culture testing capabilities across Rest Of Europe.
- Medical Device Investors : Private equity and venture capital firms need regional market analysis to evaluate investment opportunities in Rest Of Europe's expanding diagnostic sector and identify acquisition targets.
- Clinical Laboratory Operators : Independent and hospital-based laboratories need market forecasts to plan capacity expansion, technology upgrades, and service offerings aligned with regional demand trends.
- Healthcare Consultants & Analysts : Management consulting firms and market research professionals require Rest Of Europe-specific data to support client advisory services, competitive analysis, and strategic planning initiatives.
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations specific to Rest Of Europe with detailed 2026-2031 projections, enabling accurate budget allocation and investment planning for regional expansion strategies.
- Competitive Landscape Analysis : Understand Rest Of Europe's competitive dynamics, key players, and market positioning to identify partnership opportunities and competitive advantages in this high-growth region.
- Growth Driver Identification : Discover region-specific factors driving the 9.0% CAGR, including healthcare infrastructure developments, regulatory changes, and clinical adoption trends unique to Rest Of Europe.
- Strategic Market Entry Planning : Leverage Rest Of Europe-focused insights to develop targeted market entry strategies, distribution partnerships, and product positioning for maximum regional penetration.
- Investment Decision Support : Make informed investment and acquisition decisions with comprehensive Rest Of Europe market data, growth trajectories, and opportunity assessment for diagnostic companies.
Frequently asked questions
What is the projected market size for blood culture tests in Rest Of Europe by 2031?
Rest Of Europe's blood culture tests market is forecast to reach USD 615.1 million by 2031, up from USD 399.1 million in 2026.
What is the CAGR for blood culture tests in Rest Of Europe?
Rest Of Europe's blood culture tests market is expected to grow at a 9.0% compound annual growth rate between 2026 and 2031.
How does Rest Of Europe's growth compare to global market trends?
Rest Of Europe's 9.0% CAGR significantly outpaces the global blood culture tests market CAGR of 6.1%, demonstrating stronger regional momentum.
What factors are driving growth in Rest Of Europe's blood culture tests market?
Key drivers in Rest Of Europe include rising bloodstream infection prevalence, aging populations, increased sepsis awareness, and adoption of automated diagnostic systems.
Which countries are included in Rest Of Europe for this market analysis?
Rest Of Europe encompasses all European nations outside the major Western European markets, representing diverse healthcare systems and diagnostic adoption rates.
RESEARCH METHODOLOGY
The objective of this study is to analyze key market dynamics, including drivers, opportunities, restraints, and challenges, as well as the strategies of major players. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study will examine the competitive landscape of the blood culture tests market by evaluating market participants based on various criteria within the overarching categories of business and product strategy. To estimate the market size, both top-down and bottom-up approaches were employed. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
Note: C-level executives include Chief Executive Officers (CEOs), Chief Financial Officers (CFOs), Chief Operating Officers (COOs), and Vice Presidents (VPs).
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenue figures were calculated using revenue mapping for major product manufacturers and OEMs active in the global blood culture tests market. All major product manufacturers were identified at the global and/or country-/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Additionally, the global market was split into various segments and subsegments:
- List of major players in the product market by region or country
- Product mapping of various blood culture product manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from blood culture test products (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
- Summation of revenue of all companies to arrive at the global blood culture tests market size
The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Data Triangulation
After determining the overall size of the global blood culture tests market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market-related data was triangulated by studying various macro indicators and regional trends from demand- and supply-side participants.
Market Definition
Blood culture testing detects the presence of microbes such as bacteria, yeast, and other microorganisms in a blood specimen. This type of testing determines the nature and severity of blood infections, identifies the causative organisms of blood infections, and helps prevent adverse consequences.
Key Stakeholders
- Molecular diagnostics companies
- Clinical microbiology instrument and consumable manufacturers
- Research and consulting firms
- Clinical diagnostic laboratories
- Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and
- governing bodies)
- Medical device vendors/service providers
- Research institutes
- Venture capitalists and investors
Report Objectives
- To describe, segment, and forecast the blood culture tests market, by product, method, technology, application, and end user, in terms of value
- To forecast the size of the blood culture tests market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa, in terms of value
- To provide detailed information about the factors (drivers, restraints, opportunities, and challenges) influencing market growth
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall blood culture tests market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To profile the key players in the blood culture tests market and comprehensively analyze their core competencies and market shares
- To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the market
- To benchmark players within the blood culture tests market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Available customizations:
Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
- Further breakdown of the Rest of European blood culture tests market into Russia, Switzerland, Denmark, Austria, and others
- Further breakdown of the Rest of Asia Pacific blood culture tests market into Hong Kong, Taiwan, and others
- Further breakdown of the Rest of Latin American blood culture tests market into Argentina, Colombia, Chile, Ecuador, and others
- Further breakdown of the Southeast Asian blood culture tests market into Malaysia, Singapore, Australia, New Zealand, and others
COMPETITIVE LANDSCAPE ASSESSMENT
- Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the blood culture tests market
- Competitive leadership mapping for established players in the US
Get the Full Blood Culture Tests Market Report
Full forecast, segment splits, and company analysis for all Blood Culture Tests Market.
- Canada Blood Culture Tests Market
- US Blood Culture Tests Market
- Germany Blood Culture Tests Market
- UK Blood Culture Tests Market
- France Blood Culture Tests Market
- Italy Blood Culture Tests Market
- Spain Blood Culture Tests Market
- China Blood Culture Tests Market
- Japan Blood Culture Tests Market
- India Blood Culture Tests Market
- Brazil Blood Culture Tests Market
- Mexico Blood Culture Tests Market
- Rest Of Asia Pacific Blood Culture Tests Market
- Rest Of Latin America Blood Culture Tests Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
